Navigation Links
Weekly Digest's Investor Essentials Special Report Identifies Unique Investing Opportunities in the H1N1 'Swine Flu' Outbreak
Date:10/14/2009

PRINCETON, N.J., Oct. 14 /PRNewswire/ -- Weekly Digest (http://www.bullmarket.com/digest), a free investment research publication, announced the publication of a special report on investment opportunities in the connection with the H1N1 "Swine Flu" Outbreak, including updated outlooks for Gilead Sciences (Nasdaq: GILD), Sinovac Biotech (Amex: SVA), Dynavax Technologies (Nasdaq: DVAX), Hemispherx BioPharma (Amex: HEB), BioCryst Pharmaceuticals (Nasdaq: BCRX) and several others.

After posting large gains throughout 2009, swine flu stocks are seeing their largest pullback yet. For investors looking to position their portfolios for flu season, there are more ways to trade the flu than ever. Investors have large-cap pharmaceutical plays to choose from, and some of the more volatile, small-cap names have proven the efficacy of their drugs, while others are too far behind in their clinical trials to capitalize on the current pandemic.

To receive a free, 23-page report offering in depth analysis of the various participants in the vaccine and antiviral market, as well as some peripheral plays focusing directly on the impact of the current H1N1 swine flu pandemic, please visit the following link:

http://www.bullmarket.com/digest/signup.php?refer=pr1_swineflu


'/>"/>
SOURCE Indie Research Advisors, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
2. Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight
3. After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008
4. (RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa
5. Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback
6. Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study
7. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
8. Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009
9. Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study
10. Exelixis Announces September 5 Webcast of Its 2007 IASLC Investor and Analyst Briefing
11. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... -- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ) today announced data ... in a Phase 1 investigator-sponsored study at the University ... presented at the 2015 American Society of Clinical Oncology ... Results from this study show a tolerable safety ... given intravenously.  Based in part on the ...
(Date:6/1/2015)... PARK, Calif. , June 1, 2015 ... device company that is providing innovative evidence-based solutions for ... has commenced an underwritten public offering of its common ... Nevro and 2,459,175 shares to be sold by certain ... the underwriters a 30-day option to purchase up to ...
(Date:6/1/2015)... Eastern MRI systems market is fast growing. MRI being a ... medicine like cardiology, neurology and orthopedics. It is replacing older ... as safer tool as it does not use ionizing radiations. ... Open system, closed system and straight or upright system. The ... is preferred over that currently common closed type as it ...
Breaking Medicine Technology:Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 2Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 3Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 4Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 5Nevro Announces Proposed Public Offering of Common Stock 2Nevro Announces Proposed Public Offering of Common Stock 3Middle East MRI Market - Growth, Trends And Forecasts (2014 - 2019) 2Middle East MRI Market - Growth, Trends And Forecasts (2014 - 2019) 3
... researchers analyzing genetic influences in attention-deficit/hyperactivity disorder (ADHD) ... important brain signaling pathways. The study raises the ... offer a new treatment option for patients with ... million U.S. children. "At least 10 ...
... Dec. 2, 2011  MedinCell, a leading developer of ... partnerships for key companion and food animal markets ... Health Congress in Kansas City (December 6-8, 2011). ... control over the duration of drug release, thereby ...
Cached Medicine Technology:New Gene Study of ADHD Points to Defects in Brain Signaling Pathways 2New Gene Study of ADHD Points to Defects in Brain Signaling Pathways 3New Gene Study of ADHD Points to Defects in Brain Signaling Pathways 4MedinCell to Explore Controlled-Release Drug Delivery Partnerships at the World Animal Health Congress 2
(Date:6/1/2015)... Sharenote, a leading web-base electronic healthcare software (EHR) is ... in Louisiana. The entrepreneurial trio behind Sharenote, will travel ... providers with the tools and resources to monitor key ... network. , Find out why Sharenote is the ... than 250 practices. , Four Day Schedule ...
(Date:6/1/2015)... There’s never a good time to be sick and need ... , As of June 1, OSF HealthCare is offering ... the Internet. Patients throughout Illinois can access care whenever they ... busy. We know that getting in to see a provider ... it easier,” said Jeffry Tillery, MD, Chief Transformation Officer for ...
(Date:6/1/2015)... Hexagon Geospatial is pleased to announce the launch ... service that provides on-demand access to the company’s world-class ... IMAGINE and GeoMedia are now available ... subscription model for delivering software products as an online ... quickly and easily access the right tools that help ...
(Date:6/1/2015)... June 01, 2015 Good360 announced ... the Irene W. and C.B. Pennington Foundation, Louisiana’s ... board of directors. Bertman joins Good360 just before ... this summer. , "Bringing with her many years ... am thrilled that Lori is joining the Good360 ...
(Date:6/1/2015)... Triple C announced today that they will be ... this year on RFD-TV. , From the humble, farm shop ... the today’s full line of rugged products, Triple C, Inc. ... , In this segment, American Farmer will explore how ... thrive in the tough conditions on North American ranches. Viewers ...
Breaking Medicine News(10 mins):Health News:OSF HealthCare Now Offering OSF OnCall 2Health News:OSF HealthCare Now Offering OSF OnCall 3Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 2Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 3Health News:Lori Bertman Joins Good360 Board of Directors 2Health News:Triple C to Be Featured in Upcoming Episode of American Farmer 2
... non-serious side effects , , FRIDAY June 27 (HealthDay News) ... marijuana plant don,t increase the risk of serious side ... non-serious side effects, Canadian scientists report. , The researchers ... British Columbia (UBC) examined adverse events reported in 31 ...
... (PTCB), the leading national program that has ... and congratulates the Florida House of Representatives ... requiring new standards for pharmacy technicians. The ... toward increasing patient safety for consumers. The ...
... /PRNewswire-FirstCall/,-- Schering-Plough Corp. (NYSE: SGP ) and ... the withdrawal of the New Drug Application (NDA) ... terminated the Schering-Plough/Merck Pharmaceuticals,respiratory joint venture, which was ... fixed-combination product that would combine loratadine and,montelukast. This ...
... 27 Health care facilities,in the U.S. are ... infections (HAI). Could there be hidden areas of,infection ... education program,from the production company Mission Critical attempts ... Areas of Infection,",( http://www.missioncriticaltv.com/index-8-1.html ) documents how an ...
... to the latest,report by the American Lung Association, Lung ... increasing while death rates due to other,leading causes of ... Chronic obstructive pulmonary disease (COPD) is expected to,become the ... American Lung Association publishes Lung Disease Data to serve ...
... a World Health Organization expert on E. coli ... Bioniche Life Sciences,Inc. (TSX: BNC), a research-based, technology-driven ... this week,entitled, "E. coli O157 Vaccine: Added Value ... from the food industry: Beef,dairy, and other agricultural ...
Cached Medicine News:Health News:Drugs With Marijuana Compounds Don't Boost Adverse Events 2Health News:Pharmacy Technician Certification Board (PTCB) Supports Florida's New Patient Safety Solution 2Health News:Pharmacy Technician Certification Board (PTCB) Supports Florida's New Patient Safety Solution 3Health News:Hidden Areas of Infection in U.S. Hospitals 2Health News:Hidden Areas of Infection in U.S. Hospitals 3Health News:American Lung Association Report Finds Lung Disease Death Rates Increasing While Cancer, Heart Disease and Stroke Death Rates Are Decreasing 2Health News:American Lung Association Report Finds Lung Disease Death Rates Increasing While Cancer, Heart Disease and Stroke Death Rates Are Decreasing 3Health News:Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference 2Health News:Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference 3Health News:Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference 4Health News:Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference 5
... Accurate Quantitation of DNA, RNA, Or Fluorescent ... and RNA is critical to life science research. ... way to measure quantities as small as 1ng/ml ... another set of excitation and emission filters, the ...
The Fluoroskan Ascent FL is equipped with both fluorometric and luminometric measurement technologies, providing a full coverage for fluorometric, glow and flash luminometric applications even in the...
... DyNA Quant™ 200 is a ... excitation and 460 nm emission. The ... the detection of double-stranded DNA using ... assay, which minimizes interference from the ...
... is a multifunctional single ... give you utmost flexibility ... and absorbance. Modulus operates ... dedicated luminometer, or a ...
Medicine Products: